Aktiesnakken — Juni 2013
-
fik mig ihvertfald en god snak med Rachel
-
hvormange var tilstede?
-
svært at vurdere. tror vi var en 50 stykker der lyttede til rachel
-
mødte repsac. Utroligt han turde kalde sig den pæneste over 25 når han kommer daskende i en hot hawaiskjorte med solbriller hængende

-
;.)
-
Smider et resume om et par timer

-
fedt i89.
-
Mig og bassemanden var dog lidt halfærdige af grin da "hosten" blev ved med at kalde rachel for "Rakel"
-
hahaha
-
http://finance.yahoo.com/news/tesla-demo-road-battery-swapping-175553857.html shorterne tror de skal score kassen, mange mener at springer var for højt. Jeg mener at Musk er vanvittigt dygtig.
-

-
-
Bagsværd, Denmark & Plainsboro, NJ 18 June 2013 - Today, the U.S. Court of Appeals for the Federal Circuit partially affirmed a 2011 District Court decision, with a 2-1 ruling that a claim in a Novo Nordisk patent related to the use of repaglinide in combination with metformin for the treatment of type 2 diabetes was invalid. This decision favors approval and launch of a generic repaglinide product.
The Federal Circuit also reversed, with a unanimous 3-0 ruling, the District Court decision that
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
(repaglinide)